Home › Funds › Peapod Lane Capital LLC › LAB
Peapod Lane Capital LLC position in LAB
STANDARD BIOTOOLS INC · Industrials
Peapod Lane Capital LLC reported holding 2,248,249 shares of LAB (STANDARD BIOTOOLS INC) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 1.24% of its reported portfolio and ranking #35 among its reported holdings. Peapod Lane Capital LLC has disclosed LAB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-10-22 · Source: SEC EDGAR Form 13F-HR
How Peapod Lane Capital LLC's LAB position evolved
Peapod Lane Capital LLC first disclosed a stake in LAB in Q1 2026 at 2,028,527 shares (US$1.9M). The position peaked in Q2 2026 at 2,411,474 shares, worth US$2.0M. Across 3 filings, Peapod Lane Capital LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,248,249 shares valued at US$1.7M — a reduction of -163,225 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.03M | $1.86M | New |
| Q2 2026 | 2.41M | $1.98M | Add |
| Q3 2026 | 2.25M | $1.67M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LAB and 13F data
LAB (STANDARD BIOTOOLS INC) is a Industrials company. 22 other funds we track also report a position in LAB — the largest reported positions include Casdin Capital (US$73.0M), MAK CAPITAL ONE LLC (US$23.7M), Long Focus Capital Management, LLC (US$19.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LAB
- Casdin Capital 88.78M sh · $73.04M · Q2 2026
- MAK CAPITAL ONE LLC 28.81M sh · $23.71M · Q2 2026
- Long Focus Capital Management, LLC 23.50M sh · $19.33M · Q2 2026
- Hollow Brook Wealth Management LLC 5.50M sh · $4.53M · Q2 2026
- Tikvah Management LLC 3.55M sh · $2.92M · Q2 2026
More on Peapod Lane Capital LLC
FAQ
How long has Peapod Lane Capital LLC held LAB?
Peapod Lane Capital LLC has disclosed LAB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Peapod Lane Capital LLC's current position in LAB?
As of Q3 2026, Peapod Lane Capital LLC holds 2.25M shares of LAB (STANDARD BIOTOOLS INC), valued at $1.67M, representing 1.24% of its reported portfolio and ranking #35.
Has Peapod Lane Capital LLC been buying or selling LAB?
In the latest 13F filing (Q3 2026), Peapod Lane Capital LLC reduced its position in LAB. The position peaked in Q2 2026 at 2.41M shares.
Which other funds hold LAB?
Other major institutional holders of LAB include Casdin Capital, MAK CAPITAL ONE LLC, Long Focus Capital Management, LLC, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.